Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Assets
Cash	$ 316,852	$ 337,664
Cash collateral posted to counterparties	9,297	18,552
Investments in securities, at fair value
Derivatives, at fair value	543,229	199,073
Accrued interest receivable	17,412	10,570
Prepaid and other	57,733	1,094
Subordinated loan to BUCKLER	105,000	105,000
Total Assets	8,706,889	5,277,307
Liabilities:
Repurchase agreements	6,440,004	3,948,037
Cash collateral posted by counterparties	549,658	171,060
Payable for unsettled purchases	687,250	0
Derivatives, at fair value	531	10,900
Accrued interest payable- repurchase agreements	964	944
Accounts payable and other accrued expenses	6,547	2,727
Total Liabilities	7,684,954	4,133,668
Commitments and contingencies (Note 8)
Stockholders’ Equity:
Common stock, $0.001 par value, 200,000 shares authorized; 100,361 shares and 94,152 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively.	100	94
Additional paid-in capital	3,458,492	3,403,127
Cumulative distributions to stockholders	(1,870,058)	(1,837,955)
Accumulated net loss	(595,041)	(528,607)
Accumulated other comprehensive income	28,435	106,973
Total Stockholders’ Equity	1,021,935	1,143,639
Total Liabilities and Stockholders’ Equity	8,706,889	5,277,307
Agency Securities
Investments in securities, at fair value
Investment securities	6,399,346	4,406,521
U.S. Treasuries
Investments in securities, at fair value
Investment securities	1,258,020	198,833
7.00% Series C
Stockholders’ Equity:
Preferred stock, $0.001 par value, 50,000 shares authorized; 7.00% Series C Cumulative Preferred Stock; 6,847 shares issued and outstanding ($25.00 per share liquidation preference)	$ 7	$ 7